Literature DB >> 18092939

Analgesic resveratrol?

Aldo Bertelli, Mario Falchi, Bassam Dib, Elena Pini, Subhendu Mukherjee, Dipak K Das.   

Abstract

Resveratrol, a red wine and grape-derived phytoalexin, possesses diverse biochemical and physiological functions that are relevant to human health and disease. The emergent properties of resveratrol have forced us to rethink the biomedical significance of the wine culture. Novel observations point to the hypothesis that intracerebral resveratrol treatment diminishes the sensitivity of rats to pain, and that the said analgesic action of resveratrol is a central mechanism mediated by the inhibition of cycloxygenases I and II. This novel implication of resveratrol and perhaps red wine drinking warrants further studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18092939     DOI: 10.1089/ars.2007.1926

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

Review 1.  Resveratrol and red wine, healthy heart and longevity.

Authors:  Dipak K Das; Subhendu Mukherjee; Diptarka Ray
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

2.  Dose-dependency of resveratrol in providing health benefits.

Authors:  Subhendu Mukherjee; Jocelyn I Dudley; Dipak K Das
Journal:  Dose Response       Date:  2010-03-18       Impact factor: 2.658

Review 3.  Erratum to: resveratrol and red wine, healthy heart and longevity.

Authors:  Dipak K Das; Subhendu Mukherjee; Diptarka Ray
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

4.  Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19).

Authors:  Marvin R McCreary; Patrick M Schnell; Dale A Rhoda
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

5.  Randomized Double-blind Placebo-controlled Proof-of-concept Trial of Resveratrol for Outpatient Treatment of Mild Coronavirus Disease (COVID-19).

Authors:  Marvin R McCreary; Patrick M Schnell; Dale A Rhoda
Journal:  Res Sq       Date:  2021-09-13

6.  Modulation of TRP channels by resveratrol and other stilbenoids.

Authors:  Lina Yu; Shenglan Wang; Yoko Kogure; Satoshi Yamamoto; Koichi Noguchi; Yi Dai
Journal:  Mol Pain       Date:  2013-02-15       Impact factor: 3.395

7.  Resveratrol inhibits Cdk5 activity through regulation of p35 expression.

Authors:  Elias Utreras; Anita Terse; Jason Keller; Michael J Iadarola; Ashok B Kulkarni
Journal:  Mol Pain       Date:  2011-07-07       Impact factor: 3.395

Review 8.  The Plant-Derived Compound Resveratrol in Brain Cancer: A Review.

Authors:  Terezia Kiskova; Peter Kubatka; Dietrich Büsselberg; Monika Kassayova
Journal:  Biomolecules       Date:  2020-01-19

9.  pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia.

Authors:  Lin Liu; Wendong Yao; Xiaowei Xie; Jianqing Gao; Xiaoyang Lu
Journal:  J Nanobiotechnology       Date:  2021-08-06       Impact factor: 10.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.